Abstract:ShenMai Injection (SMI) is a traditional Chinese medicine that has been extensively applied in the treatment of coronary artery disease and tumor for many years. However, there is still lack of deep research on the behaviors of SMI in vivo. In this study, a reliable, specific, and sensitive method was developed for simultaneous determination of sixteen saponins found in SMI using liquid chromatography tandem mass spectrometry (LC-MS/MS). This method was successfully applied to investigate the pharmacokinetics, tissue distribution and excretion of sixteen active compounds after a single intravenous administration of SMI. These compounds included seven protopapaxdiol (PPD-type) ginsenosides (ginsenosides Rb1, Rb2, Rb3, Rc, Rd, S-Rg3, R-Rg3), six protopapaxtriol (PPT-type) ginsenosides (notoginsenoside R1, ginsenosides Re, Rf, Rg1, S-Rg2, R-Rg2), one oleanolic acid type ginsenoside (ginsenoside Ro) and two ophiopogonins (ophiopogonin D (MD-D) and ophiopogonin D' (MD-D')). Connection of the C-20 hydroxyl group to the glycoside and the chiral configuration of C-20 might significantly impact the pharmacokinetic behaviors in vivo of ginsenosides, particularly PPD-type ginsenosides. PPD-type ginsenosides were usually eliminated slowly in serum and tissues, but S/R-Rg3 bearing a free hydroxyl group at C-20 exhibited quick elimination, and R-Rg3 underwent quicker elimination than S-Rg3. The PPT-type ginsenosides, oleanolic acid type ginsenoside and ophiopogonins underwent a fast elimination from serum and tissues. There were 10 ginsenosides that could penetrate the blood-brain barrier. In contrast to other saponins, the distributions of S-Rg2, R-Rg2, S-Rg3, R-Rg3, MD-D and MD-D' in liver were higher than in kidney. Several PPD-type ginsenosides were found to have a long-term accumulation risk in some tissues, especially Rd in kidney. In the excretion study, Rg1, S-Rg2 and MD-D were mainly excreted in a prototype and other saponins were mainly excreted in the form of metabolites. Prototypes of S-Rg2, R-Rg2, S-Rg3, R-Rg3, MD-D and MD-D' exhibited higher distribution in the liver than kidney, were excreted mainly in the feces, whereas prototypes of the remaining saponins were primarily excreted via urine. To best our knowledge, this is the first study to quantitatively evaluate the tissue distribution and excretion of SMI in rats. Our research provides novel insight into the behaviors in vivo of PPD-type ginsenosides and delivers valuable information for further drug development of SMI.

Analysis of Bioactive Components and Multi-Component Pharmacokinetics of Saponins from the Leaves of Panax Notoginseng in Rat Plasma after Oral Administration by LC-MS/MS.

Pharmacokinetics, Tissue Distribution and Excretion of Saponins after Intravenous Administration of ShenMai Injection in Rats.

Simultaneous Determination Of Notoginsenoside R1, Ginsenoside Rg(1), Re, Rb-1 And Icariin In Rat Plasma By Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry

[Identification of Saponins from Panax Notoginseng in Metabolites of Rats].

Integrated metabolomic and transcriptomic analyses revealed the distribution of saponins in Panax notoginseng

Dose-dependent exposure profile and metabolic characterization of notoginsenoside R 1 in rat plasma by ultra-fast liquid chromatography-electrospray ionization-tandem mass spectrometry.

Development and Validation of an Uflc-Ms/Ms Assay for the Absolute Quantitation of Nine Notoginsenosides in Rat Plasma: Application to the Pharmacokinetic Study of Panax Notoginseng Extract

Metabolomes and transcriptomes revealed the saponin distribution in root tissues of Panax quinquefolius and Panax notoginseng

Hplc Determination Of Four Active Saponins From Panax Notoginseng In Rat Serum And Its Application To Pharmacokinetic Studies

Simultaneous Determination of Eight Ginsenosides in Rat Plasma by Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry: Application to Their Pharmacokinetics

Liquid chromatographic method for determination of four active saponins from Panax notoginseng in rat urine using solid-phase extraction.

A Rapid Ultra-Performance Liquid Chromatography-Electrospray Ionisation Mass Spectrometric Method for the Analysis of Saponins in the Adventitious Roots of Panax Notoginseng.

Metabolite profiling of ginsenosides in rat plasma, urine, and faeces by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Panax ginseng extract.

Pharmacokinetic Characteristics of Steamed Notoginseng by an Efficient LC-MS/MS Method for Simultaneously Quantifying Twenty-three Triterpenoids

Metabolic Analysis of Panax Notoginseng Saponins with Gut Microbiota-Mediated Biotransformation by HPLC-DAD-Q-TOF-MS/MS

Simultaneous Determination of Three Saponins in Human Plasma after Oral Administration of Compound Danshen Dripping Pills by LC-MS/MS and Its Application in a Pharmacokinetic Study

Liquid Chromatography Tandem Mass Spectrometry in Study of the Pharmacokinetics of Six Steroidal Saponins in Rats

Target Separation of a New Anti-Tumor Saponin and Metabolic Profiling of Leaves of Panax Notoginseng by Liquid Chromatography with Eletrospray Ionization Quadrupole Time-of-flight Mass Spectrometry.

[Analysis of Saponins from Panax Notoginseng Using Pressurized Solvent Extraction Coupled with Liquid Chromatography-Electrospray Mass Spectrum].

Simultaneous Determination of Panax Notoginsenoside R1, Ginsenoside Rg1, Rd, Re and Rb1 in Rat Plasma by HPLC/ESI/MS: Platform for the Pharmacokinetic Evaluation of Total Panax Notoginsenoside, a Typical Kind of Multiple Constituent Traditional Chinese Medicine

Simultaneous determination of three Panax notoginseng saponins at sub-nanograms by LC-MS/MS in dog plasma for pharmacokinetics of compound Danshen tablets.